CXCL17 and experimental autoimmune encephalomyelitis: A lack of such inhibition may explain, in part, the perturbed trafficking of lymphoid and myeloid cells and exacerbated disease reported in CXCL17-deficient mice utilized in a model of experimental autoimmune encephalomyelitis (EAE) (79).